Thomas Parkhouse
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Thomas Parkhouse has a total of 70 co-authors. Here are the top co-authors by number of shared publications:
- Deborah M. Caldwell
Population Health Sciences, Bristol Medical School University of Bristol Bristol UK
7 shared publications - Katie Webster
University of Bristol
6 shared publications - Julian Piers Thomas Higgins
University of Bristol
5 shared publications - Sarah Dawson
Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK
5 shared publications - Agnes Leu
Institute for Biomedical Ethics, Medical Faculty, University of Basel, 4056 Basel, Switzerland
4 shared publications - Elizabeth Hanson
Department of Health and Caring Sciences, Linnaeus University, Kalmar, Sweden
4 shared publications
Latest Publications
- Open Access
Efficacy and safety of pharmacological interventions for the treatment of cocaine use disorder: a systematic review and network meta-analysis
Background and Aims: Cocaine use disorder (CUD) is an increasingly widespread concern worldwide. Various pharmacological treatments have been investigated for CUD, but their efficacy remains unclear, and none have been licensed for treatment. Therefore, we assessed the comparative effectiveness, safety, and acceptability of pharmacological interventions for the treatment of CUD and prevention of relapse. Design: Systematic review and network meta-analyses of double-blind randomized controlled trials (RCTs). PROSPERO (CRD42024596434). We assessed risk of bias using the Cochrane Risk of Bias 2 tool and certainty of evidence was assessed using the Confidence in Network Meta-analysis framework. Setting: Any in/outpatient setting, with no restriction on geographic location. Participants: Adults with diagnosed CUD. Participants with co-occurring substance use disorders and/or common mental health conditions were eligible. Interventions: Pharmacologicalinterventions specifically tested for the treatment of CUD with a minimum follow-up of 4 weeks. Measurements: We assessed 12 effectiveness, three acceptability, and two safety outcomes. Our primary outcomes were continuous abstinence, point abstinence, dropout for any reason, and serious adverse events. We also examined longest duration of continuous abstinence, extent of cocaine use, craving, severity of dependence, dropout due to adverse events, adherence, and mortality. Findings: We included 218 reports of 163 studies (14871 participants) assessing 89 unique medications, grouped into 8 categories. Most study results had some concerns or high risk of bias, and the results of syntheses were generally judged to be very low certainty evidence. As such, the findings ought to be interpreted with caution. No single treatment type showed consistent beneficial effects across all effectiveness outcomes and there was limited evidence that results varied by intervention type or presence of co-occurring comorbidity. Conclusions: Despite continued work in this area, effective pharmacological treatments for CUD remain elusive.
Open AccessEfficacy and safety of pharmacological interventions for the treatment of cocaine use disorder: a systematic review and network meta-analysis
Background and Aims: Cocaine use disorder (CUD) is an increasingly widespread concern worldwide. Various pharmacological treatments have been investigated for CUD, but their efficacy remains unclear, and none have been licensed for treatment. Therefore, we assessed the comparative effectiveness, safety, and acceptability of pharmacological interventions for the treatment of CUD and prevention of relapse. Design: Systematic review and network meta-analyses of double-blind randomized controlled trials (RCTs). PROSPERO (CRD42024596434). We assessed risk of bias using the Cochrane Risk of Bias 2 tool and certainty of evidence was assessed using the Confidence in Network Meta-analysis framework. Setting: Any in/outpatient setting, with no restriction on geographic location. Participants: Adults with diagnosed CUD. Participants with co-occurring substance use disorders and/or common mental health conditions were eligible. Interventions: Pharmacologicalinterventions specifically tested for the treatment of CUD with a minimum follow-up of 4 weeks. Measurements: We assessed 12 effectiveness, three acceptability, and two safety outcomes. Our primary outcomes were continuous abstinence, point abstinence, dropout for any reason, and serious adverse events. We also examined longest duration of continuous abstinence, extent of cocaine use, craving, severity of dependence, dropout due to adverse events, adherence, and mortality. Findings: We included 218 reports of 163 studies (14871 participants) assessing 89 unique medications, grouped into 8 categories. Most study results had some concerns or high risk of bias, and the results of syntheses were generally judged to be very low certainty evidence. As such, the findings ought to be interpreted with caution. No single treatment type showed consistent beneficial effects across all effectiveness outcomes and there was limited evidence that results varied by intervention type or presence of co-occurring comorbidity. Conclusions: Despite continued work in this area, effective pharmacological treatments for CUD remain elusive.
- Open Access
- 28 November 2025
- Published by National Institute for Health and Care Research in NIHR Open Research
- Vol. 5, 51
The effects of sunlight exposure on mortality: a systematic review of epidemiological studies
Introduction Current sun safety advice focuses on minimizing exposure to sunlight, due to the relationship between ultraviolet radiation and skin cancer. However, sunlight also has beneficial effects, and there are calls for guidance to reflect these alongside the harmful effects. To examine the net effect of harmful and beneficial aspects, we aimed to determine the association between sunlight exposure and all-cause mortality. Additionally, we examined cause-specific mortality and whether the associations varied according to skin type/colour or ethnicity. Methods We conducted a systematic review, searching MEDLINE, Embase, Web of Science and the Cochrane Central Register of Controlled Trials (Nov 2023) for reports of epidemiological studies in the general population investigating the effect of long-term sun exposure on all-cause, cardiovascular-related, or cancer-related mortality. We conducted a narrative synthesis of the findings and assessed risk of bias using the ROBINS-E tool. PROSPERO: CRD42023474157. Results The search identified 73 eligible articles, with 55 included in the narrative synthesis. Methods of measuring sunlight exposure comprised radiation, proxy measures of radiation (e.g., latitude) and behaviour associated with sunlight exposure. The evidence was mixed. While most studies of skin cancer mortality found a higher risk associated with more exposure to sunlight, many studies of other cancers reported lower associated risk. Evidence for all-cause mortality was mixed, as were findings for cardiovascular mortality. Results were subject to high risk of bias, largely due to the likelihood of uncontrolled confounding and the use of indirect measures of sunlight exposure. There were insufficient data regarding any differential effects of sunlight on mortality for those of different skin types/colours or ethnicity. Conclusion Findings from observational epidemiological studies of the association between sunlight exposure and mortality vary across different disease outcome and location being investigated. As such, the findings do not provide a strong rationale for changes to sun protection guidance.
- 28 November 2025
- Published by National Institute for Health and Care Research in NIHR Open Research
- Vol. 5, 51
Open AccessThe effects of sunlight exposure on mortality: a systematic review of epidemiological studies
Introduction Current sun safety advice focuses on minimizing exposure to sunlight, due to the relationship between ultraviolet radiation and skin cancer. However, sunlight also has beneficial effects, and there are calls for guidance to reflect these alongside the harmful effects. To examine the net effect of harmful and beneficial aspects, we aimed to determine the association between sunlight exposure and all-cause mortality. Additionally, we examined cause-specific mortality and whether the associations varied according to skin type/colour or ethnicity. Methods We conducted a systematic review, searching MEDLINE, Embase, Web of Science and the Cochrane Central Register of Controlled Trials (Nov 2023) for reports of epidemiological studies in the general population investigating the effect of long-term sun exposure on all-cause, cardiovascular-related, or cancer-related mortality. We conducted a narrative synthesis of the findings and assessed risk of bias using the ROBINS-E tool. PROSPERO: CRD42023474157. Results The search identified 73 eligible articles, with 55 included in the narrative synthesis. Methods of measuring sunlight exposure comprised radiation, proxy measures of radiation (e.g., latitude) and behaviour associated with sunlight exposure. The evidence was mixed. While most studies of skin cancer mortality found a higher risk associated with more exposure to sunlight, many studies of other cancers reported lower associated risk. Evidence for all-cause mortality was mixed, as were findings for cardiovascular mortality. Results were subject to high risk of bias, largely due to the likelihood of uncontrolled confounding and the use of indirect measures of sunlight exposure. There were insufficient data regarding any differential effects of sunlight on mortality for those of different skin types/colours or ethnicity. Conclusion Findings from observational epidemiological studies of the association between sunlight exposure and mortality vary across different disease outcome and location being investigated. As such, the findings do not provide a strong rationale for changes to sun protection guidance.
- Open Access
- 18 June 2025
- Published by National Institute for Health and Care Research in NIHR Open Research
- Vol. 5, 51
The effects of sunlight exposure on mortality: a systematic review of epidemiological studies
Introduction Current sun safety advice focuses on minimizing exposure to sunlight, due to the relationship between ultraviolet radiation and skin cancer. However, sunlight also has beneficial effects, and there are calls for guidance to reflect these alongside the harmful effects. To examine the net effect of harmful and beneficial aspects, we aimed to determine the association between sunlight exposure and all-cause mortality. Additionally, we examined cause-specific mortality and whether the associations varied according to skin type/colour or ethnicity. Methods We conducted a systematic review, searching MEDLINE, Embase, Web of Science and the Cochrane Central Register of Controlled Trials (Nov 2023) for reports of epidemiological studies in the general population investigating the effect of any measure of long-term sun exposure on all-cause, cardiovascular-related, or cancer-related mortality. We conducted a narrative synthesis of the findings and assessed risk of bias using the ROBINS-E tool. PROSPERO: CRD42023474157. Results The search identified 73 eligible articles. Methods of measuring sunlight exposure comprised radiation (e.g., ultraviolet radiation levels), proxy measures of radiation (e.g., latitude) and behaviour associated with sunlight exposure (e.g., frequency of sunbathing). The evidence was inconclusive. While most studies of skin cancer mortality found a higher risk associated with more exposure to sunlight, many studies of other cancers reported lower risks associated with more exposure to sunlight. Evidence for all-cause mortality was mixed, as were findings for cardiovascular mortality. Results were subject to high risk of bias, largely due to the likelihood of uncontrolled confounding and the use of indirect measures of sunlight exposure. There were insufficient data regarding any differential effects of sunlight on mortality for those of different skin types/colours or ethnicity. Conclusion Findings from observational epidemiological studies of the association between sunlight exposure and mortality are too variable to provide a strong rationale for changes to sun protection guidance.
- 18 June 2025
- Published by National Institute for Health and Care Research in NIHR Open Research
- Vol. 5, 51
Open AccessThe effects of sunlight exposure on mortality: a systematic review of epidemiological studies
Introduction Current sun safety advice focuses on minimizing exposure to sunlight, due to the relationship between ultraviolet radiation and skin cancer. However, sunlight also has beneficial effects, and there are calls for guidance to reflect these alongside the harmful effects. To examine the net effect of harmful and beneficial aspects, we aimed to determine the association between sunlight exposure and all-cause mortality. Additionally, we examined cause-specific mortality and whether the associations varied according to skin type/colour or ethnicity. Methods We conducted a systematic review, searching MEDLINE, Embase, Web of Science and the Cochrane Central Register of Controlled Trials (Nov 2023) for reports of epidemiological studies in the general population investigating the effect of any measure of long-term sun exposure on all-cause, cardiovascular-related, or cancer-related mortality. We conducted a narrative synthesis of the findings and assessed risk of bias using the ROBINS-E tool. PROSPERO: CRD42023474157. Results The search identified 73 eligible articles. Methods of measuring sunlight exposure comprised radiation (e.g., ultraviolet radiation levels), proxy measures of radiation (e.g., latitude) and behaviour associated with sunlight exposure (e.g., frequency of sunbathing). The evidence was inconclusive. While most studies of skin cancer mortality found a higher risk associated with more exposure to sunlight, many studies of other cancers reported lower risks associated with more exposure to sunlight. Evidence for all-cause mortality was mixed, as were findings for cardiovascular mortality. Results were subject to high risk of bias, largely due to the likelihood of uncontrolled confounding and the use of indirect measures of sunlight exposure. There were insufficient data regarding any differential effects of sunlight on mortality for those of different skin types/colours or ethnicity. Conclusion Findings from observational epidemiological studies of the association between sunlight exposure and mortality are too variable to provide a strong rationale for changes to sun protection guidance.
- Open Access
Effectiveness and safety of psychosocial interventions for the treatment of cannabis use disorder: A systematic review and meta‐analysis
Aim: To evaluate the effectiveness, safety and cost‐effectiveness of psychosocial interventions for cannabis use disorder (CUD).Methods: A systematic review of randomized controlled trials (RCTs; PROSPERO protocol CRD42024553382) of psychosocial interventions for CUD lasting >4 sessions, delivered synchronously, to individuals with CUD aged ≥16 years, in inpatient, outpatient or community‐based settings. We searched databases (MEDLINE/PsycInfo/Cochrane CENTRAL) to 12 June 2024. We assessed results using Risk of Bias 2 and conducted pairwise meta‐analyses. Primary outcomes were continuous‐ and point‐abstinence and withdrawal intensity at the end of treatment, treatment completion and adverse events.Results: We included 22 RCTs (3304 participants). Relative to an inactive/non‐specific comparator, cognitive‐behavioural therapy with motivation enhancement (MET‐CBT) increased point abstinence [odds ratio (OR) = 18.27; 95% confidence interval (9.00−37.07)] and continuous abstinence [OR = 2.72; (1.20−6.19)], but reduced treatment completion [OR = 0.53; (0.35−0.85)]. Dialectical behavioural/acceptance and commitment therapy increased point abstinence versus inactive/non‐specific comparator [OR = 4.34; (1.74−10.80)]. The effect of MET‐CBT plus affect management versus MET‐CBT on point abstinence was OR = 7.85 (0.38−163.52). The effect of MET‐CBT plus abstinence‐based contingency management versus MET‐CBT on point abstinence was OR = 3.78 (0.83−17.25), and on continuous abstinence OR = 1.81 (0.61−5.41). For MET‐CBT plus abstinence‐contingency management versus MET‐CBT plus attendance‐contingency management, the effect on point abstinence was OR = 1.61 (0.72−3.60), and on continuous abstinence OR = 2.04 (0.75−5.58). The effect of community reinforcement on point abstinence was OR = 0.29 (0.04−1.90) versus MET‐CBT, and on continuous abstinence OR = 47.36 (16.00−140.21) versus non‐specific comparator. Interventions other than MET‐CBT may not affect treatment completion. No adverse events were reported. No study reported withdrawal intensity. Two economic evaluations reported higher costs for more complex interventions and contingency management.Conclusions: Cognitive‐behavioural therapy with motivation enhancement and dialectical behavioural/acceptance and commitment therapy may increase abstinence among people with cannabis use disorder relative to an inactive/non‐specific comparator. The conclusions remain tentative due to low‐ to very low‐certainty evidence and the small number of studies.
Open AccessEffectiveness and safety of psychosocial interventions for the treatment of cannabis use disorder: A systematic review and meta‐analysis
Aim: To evaluate the effectiveness, safety and cost‐effectiveness of psychosocial interventions for cannabis use disorder (CUD).Methods: A systematic review of randomized controlled trials (RCTs; PROSPERO protocol CRD42024553382) of psychosocial interventions for CUD lasting >4 sessions, delivered synchronously, to individuals with CUD aged ≥16 years, in inpatient, outpatient or community‐based settings. We searched databases (MEDLINE/PsycInfo/Cochrane CENTRAL) to 12 June 2024. We assessed results using Risk of Bias 2 and conducted pairwise meta‐analyses. Primary outcomes were continuous‐ and point‐abstinence and withdrawal intensity at the end of treatment, treatment completion and adverse events.Results: We included 22 RCTs (3304 participants). Relative to an inactive/non‐specific comparator, cognitive‐behavioural therapy with motivation enhancement (MET‐CBT) increased point abstinence [odds ratio (OR) = 18.27; 95% confidence interval (9.00−37.07)] and continuous abstinence [OR = 2.72; (1.20−6.19)], but reduced treatment completion [OR = 0.53; (0.35−0.85)]. Dialectical behavioural/acceptance and commitment therapy increased point abstinence versus inactive/non‐specific comparator [OR = 4.34; (1.74−10.80)]. The effect of MET‐CBT plus affect management versus MET‐CBT on point abstinence was OR = 7.85 (0.38−163.52). The effect of MET‐CBT plus abstinence‐based contingency management versus MET‐CBT on point abstinence was OR = 3.78 (0.83−17.25), and on continuous abstinence OR = 1.81 (0.61−5.41). For MET‐CBT plus abstinence‐contingency management versus MET‐CBT plus attendance‐contingency management, the effect on point abstinence was OR = 1.61 (0.72−3.60), and on continuous abstinence OR = 2.04 (0.75−5.58). The effect of community reinforcement on point abstinence was OR = 0.29 (0.04−1.90) versus MET‐CBT, and on continuous abstinence OR = 47.36 (16.00−140.21) versus non‐specific comparator. Interventions other than MET‐CBT may not affect treatment completion. No adverse events were reported. No study reported withdrawal intensity. Two economic evaluations reported higher costs for more complex interventions and contingency management.Conclusions: Cognitive‐behavioural therapy with motivation enhancement and dialectical behavioural/acceptance and commitment therapy may increase abstinence among people with cannabis use disorder relative to an inactive/non‐specific comparator. The conclusions remain tentative due to low‐ to very low‐certainty evidence and the small number of studies.
- Open Access
- 8 April 2025
- Published by BMJ in BMJ Medicine
- Vol. 4 (1) , e001098
Effectiveness of stress management and relaxation interventions for management of hypertension and prehypertension: systematic review and network meta-analysis
Objective: To assess whether relaxation and stress management techniques are useful in reducing blood pressure in individuals with hypertension and prehypertension. Design: Systematic review and network meta-analysis. Data sources: Medline, PsycInfo, and CENTRAL (Cochrane Central Register of Controlled Trials) from inception to 23 February 2024, and CINAHL (Cumulative Index to Nursing and Allied Health Literature) from inception to 27 February 2024. Eligibility criteria for selecting studies: Studies published in English of adults with hypertension (blood pressure ≥140/90 mm Hg) or prehypertension (blood pressure ≥120/80 mm Hg but <140/90 mm Hg). Studies that compared non-pharmacological interventions used to promote relaxation or reduce stress with each other, or with a control group (eg, no intervention, waiting list, or standard care). Where possible, network meta-analysis was used to compare the efficacy of the different interventions. Studies were assessed with the risk of bias 2 tool (RoB2), and those at high risk of bias were excluded from the primary analysis. The certainty of the evidence was assessed with CINeMA (Confidence in Network Meta-Analysis) and GRADE (Grading of Recommendations Assessment, Development, and Evaluation). Results: 182 studies were included (166 for hypertension and 16 for prehypertension). Results from a random effects network meta-analysis showed that, at short term follow-up (≤3 months), most relaxation interventions appeared to have a beneficial effect on systolic and diastolic blood pressure for individuals with hypertension. Between study heterogeneity was moderate (τ=2.62-4.73). Compared with a passive comparator (ie, no intervention, waiting list, or usual care), moderate reductions in systolic blood pressure were found for breathing control (mean difference −6.65 mm Hg, 95% credible interval −10.39 to −2.93), meditation (mean difference −7.71 mm Hg, −14.07 to −1.29), meditative movement (including tai chi and yoga, mean difference −9.58 mm Hg, −12.95 to −6.17), mindfulness (mean difference −9.90 mm Hg, −16.44 to −3.53), music (mean difference −6.61 mm Hg, −11.62 to −1.56), progressive muscle relaxation (mean difference −7.46 mm Hg, −12.15 to −2.96), psychotherapy (mean difference −9.83 mm Hg, −16.24 to −3.43), and multicomponent interventions (mean difference −6.78 mm Hg, −11.59 to −1.99). Reductions were also seen in diastolic blood pressure. Few studies conducted follow-up for more than three months, but effects on blood pressure seemed to lessen over time. Limited data were available for prehypertension; only two studies compared short term follow-up of relaxation therapies with a passive comparator, and the effects on systolic blood pressure were small (mean difference −3.84 mm Hg, 95% credible interval −6.25 to −1.43 for meditative movement; mean difference −0.53 mm Hg, −2.03 to 0.97 for multicomponent intervention). The certainty of the evidence was considered to be very low based on the CINeMA framework, owing to the risk of bias in the primary studies, potential publication bias, and imprecision in the effect estimates. Conclusions: The results of the study indicated that relaxation and stress management techniques might have beneficial short term effects on blood pressure for people with hypertension, but the effectiveness of these interventions is still uncertain. Future studies should ensure rigorous methods are used to minimise the risk of bias, and a longer duration of follow-up to establish whether these effects persist. Systematic review registration: PROSPERO CRD42023469128
- 8 April 2025
- Published by BMJ in BMJ Medicine
- Vol. 4 (1) , e001098
Open AccessEffectiveness of stress management and relaxation interventions for management of hypertension and prehypertension: systematic review and network meta-analysis
Objective: To assess whether relaxation and stress management techniques are useful in reducing blood pressure in individuals with hypertension and prehypertension. Design: Systematic review and network meta-analysis. Data sources: Medline, PsycInfo, and CENTRAL (Cochrane Central Register of Controlled Trials) from inception to 23 February 2024, and CINAHL (Cumulative Index to Nursing and Allied Health Literature) from inception to 27 February 2024. Eligibility criteria for selecting studies: Studies published in English of adults with hypertension (blood pressure ≥140/90 mm Hg) or prehypertension (blood pressure ≥120/80 mm Hg but <140/90 mm Hg). Studies that compared non-pharmacological interventions used to promote relaxation or reduce stress with each other, or with a control group (eg, no intervention, waiting list, or standard care). Where possible, network meta-analysis was used to compare the efficacy of the different interventions. Studies were assessed with the risk of bias 2 tool (RoB2), and those at high risk of bias were excluded from the primary analysis. The certainty of the evidence was assessed with CINeMA (Confidence in Network Meta-Analysis) and GRADE (Grading of Recommendations Assessment, Development, and Evaluation). Results: 182 studies were included (166 for hypertension and 16 for prehypertension). Results from a random effects network meta-analysis showed that, at short term follow-up (≤3 months), most relaxation interventions appeared to have a beneficial effect on systolic and diastolic blood pressure for individuals with hypertension. Between study heterogeneity was moderate (τ=2.62-4.73). Compared with a passive comparator (ie, no intervention, waiting list, or usual care), moderate reductions in systolic blood pressure were found for breathing control (mean difference −6.65 mm Hg, 95% credible interval −10.39 to −2.93), meditation (mean difference −7.71 mm Hg, −14.07 to −1.29), meditative movement (including tai chi and yoga, mean difference −9.58 mm Hg, −12.95 to −6.17), mindfulness (mean difference −9.90 mm Hg, −16.44 to −3.53), music (mean difference −6.61 mm Hg, −11.62 to −1.56), progressive muscle relaxation (mean difference −7.46 mm Hg, −12.15 to −2.96), psychotherapy (mean difference −9.83 mm Hg, −16.24 to −3.43), and multicomponent interventions (mean difference −6.78 mm Hg, −11.59 to −1.99). Reductions were also seen in diastolic blood pressure. Few studies conducted follow-up for more than three months, but effects on blood pressure seemed to lessen over time. Limited data were available for prehypertension; only two studies compared short term follow-up of relaxation therapies with a passive comparator, and the effects on systolic blood pressure were small (mean difference −3.84 mm Hg, 95% credible interval −6.25 to −1.43 for meditative movement; mean difference −0.53 mm Hg, −2.03 to 0.97 for multicomponent intervention). The certainty of the evidence was considered to be very low based on the CINeMA framework, owing to the risk of bias in the primary studies, potential publication bias, and imprecision in the effect estimates. Conclusions: The results of the study indicated that relaxation and stress management techniques might have beneficial short term effects on blood pressure for people with hypertension, but the effectiveness of these interventions is still uncertain. Future studies should ensure rigorous methods are used to minimise the risk of bias, and a longer duration of follow-up to establish whether these effects persist. Systematic review registration: PROSPERO CRD42023469128
- Open Access
Effectiveness and safety of psychosocial interventions for the treatment of cannabis use disorder: a systematic review and meta-analysis
Aim: To evaluate the effectiveness, safety, and cost-effectiveness of psychosocial interventions for cannabis use disorder (CUD). Design: A systematic review of randomized controlled trials (RCTs; PROSPERO protocol CRD42024553382). We searched databases (MEDLINE/PsycInfo/Cochrane CENTRAL) to 12-Jun-2024. We assessed results using Risk of Bias 2 and conducted meta-analyses where possible. Setting: Inpatient/outpatient/community-based. Participants: Individuals with CUD aged ≥16 years. Interventions: Psychosocial interventions lasting >4 sessions, delivered in real time. Measurements: Primary outcomes were continuous- and point-abstinence, withdrawal intensity, treatment completion and adverse events. Findings: We included 22 RCTs (3,304 participants). At the end of treatment, cognitive-behavioural therapy (CBT) increased point abstinence (odds ratio [OR]=18.27, 95% confidence interval [9.00; 37.07]), and continuous abstinence (OR=2.72 [1.20; 6.19]), but reduced treatment completion (OR=0.53 [0.35; 0.85]) versus inactive/nonspecific comparators. Dialectical behavioural/acceptance and commitment therapy increased point abstinence versus inactive/nonspecific comparators (OR=4.34 [1.74; 10.80]). The effect of CBT plus affect management versus CBT on point abstinence was OR=7.85 [0.38; 163.52]. The effect of CBT plus abstinence-based contingency management versus CBT on point abstinence was OR=3.78 [0.83; 17.25], and on continuous abstinence OR=1.81 [0.61; 5.41]. For CBT plus abstinence-contingency management versus CBT plus attendance-contingency management, the effect on point abstinence was OR=1.61 [0.72; 3.60], and on continuous abstinence OR=2.04 [0.75; 5.58]. The effect of community reinforcement on point abstinence was OR=0.29 [0.04; 1.90] versus CBT, and on continuous abstinence OR=47.36 [16.00; 140.21] versus nonspecific comparator. Interventions other than CBT may not affect treatment completion. No adverse events were reported. No study reported withdrawal intensity. Two economic evaluations reported higher costs for more complex psychosocial interventions and contingency management. Conclusions: Cognitive-behavioural and dialectical behavioural/acceptance and commitment therapies may increase abstinence relative to inactive/nonspecific comparators. The conclusions remain tentative due to low to very low certainty of evidence and small number of studies.
Open AccessEffectiveness and safety of psychosocial interventions for the treatment of cannabis use disorder: a systematic review and meta-analysis
Aim: To evaluate the effectiveness, safety, and cost-effectiveness of psychosocial interventions for cannabis use disorder (CUD). Design: A systematic review of randomized controlled trials (RCTs; PROSPERO protocol CRD42024553382). We searched databases (MEDLINE/PsycInfo/Cochrane CENTRAL) to 12-Jun-2024. We assessed results using Risk of Bias 2 and conducted meta-analyses where possible. Setting: Inpatient/outpatient/community-based. Participants: Individuals with CUD aged ≥16 years. Interventions: Psychosocial interventions lasting >4 sessions, delivered in real time. Measurements: Primary outcomes were continuous- and point-abstinence, withdrawal intensity, treatment completion and adverse events. Findings: We included 22 RCTs (3,304 participants). At the end of treatment, cognitive-behavioural therapy (CBT) increased point abstinence (odds ratio [OR]=18.27, 95% confidence interval [9.00; 37.07]), and continuous abstinence (OR=2.72 [1.20; 6.19]), but reduced treatment completion (OR=0.53 [0.35; 0.85]) versus inactive/nonspecific comparators. Dialectical behavioural/acceptance and commitment therapy increased point abstinence versus inactive/nonspecific comparators (OR=4.34 [1.74; 10.80]). The effect of CBT plus affect management versus CBT on point abstinence was OR=7.85 [0.38; 163.52]. The effect of CBT plus abstinence-based contingency management versus CBT on point abstinence was OR=3.78 [0.83; 17.25], and on continuous abstinence OR=1.81 [0.61; 5.41]. For CBT plus abstinence-contingency management versus CBT plus attendance-contingency management, the effect on point abstinence was OR=1.61 [0.72; 3.60], and on continuous abstinence OR=2.04 [0.75; 5.58]. The effect of community reinforcement on point abstinence was OR=0.29 [0.04; 1.90] versus CBT, and on continuous abstinence OR=47.36 [16.00; 140.21] versus nonspecific comparator. Interventions other than CBT may not affect treatment completion. No adverse events were reported. No study reported withdrawal intensity. Two economic evaluations reported higher costs for more complex psychosocial interventions and contingency management. Conclusions: Cognitive-behavioural and dialectical behavioural/acceptance and commitment therapies may increase abstinence relative to inactive/nonspecific comparators. The conclusions remain tentative due to low to very low certainty of evidence and small number of studies.
- Open Access
- 1 October 2024
- Published by National Institute for Health and Care Research in Health Technology Assessment
- p. 1-75
Diagnostic accuracy of point-of-care tests for acute respiratory infection: a systematic review of reviews
Background: Acute respiratory infections are a common reason for consultation with primary and emergency healthcare services. Identifying individuals with a bacterial infection is crucial to ensure appropriate treatment. However, it is also important to avoid overprescription of antibiotics, to prevent unnecessary side effects and antimicrobial resistance. We conducted a systematic review to summarise evidence on the diagnostic accuracy of symptoms, signs and point-of-care tests to diagnose bacterial respiratory tract infection in adults, and to diagnose two common respiratory viruses, influenza and respiratory syncytial virus. Methods: The primary approach was an overview of existing systematic reviews. We conducted literature searches (22 May 2023) to identify systematic reviews of the diagnostic accuracy of point-of-care tests. Where multiple reviews were identified, we selected the most recent and comprehensive review, with the greatest overlap in scope with our review question. Methodological quality was assessed using the Risk of Bias in Systematic Reviews tool. Summary estimates of diagnostic accuracy (sensitivity, specificity or area under the curve) were extracted. Where no systematic review was identified, we searched for primary studies. We extracted sufficient data to construct a 2 × 2 table of diagnostic accuracy, to calculate sensitivity and specificity. Methodological quality was assessed using the Quality Assessment of Diagnostic Accuracy Studies version 2 tool. Where possible, meta-analyses were conducted. We used GRADE to assess the certainty of the evidence from existing reviews and new analyses. Results: We identified 23 reviews which addressed our review question; 6 were selected as the most comprehensive and similar in scope to our review protocol. These systematic reviews considered the following tests for bacterial respiratory infection: individual symptoms and signs; combinations of symptoms and signs (in clinical prediction models); clinical prediction models incorporating C-reactive protein; and biological markers related to infection (including C-reactive protein, procalcitonin and others). We also identified systematic reviews that reported the accuracy of specific tests for influenza and respiratory syncytial virus. No reviews were found that assessed the diagnostic accuracy of white cell count for bacterial respiratory infection, or multiplex tests for influenza and respiratory syncytial virus. We therefore conducted searches for primary studies, and carried out meta-analyses for these index tests. Overall, we found that symptoms and signs have poor diagnostic accuracy for bacterial respiratory infection (sensitivity ranging from 9.6% to 89.1%; specificity ranging from 13.4% to 95%). Accuracy of biomarkers was slightly better, particularly when combinations of biomarkers were used (sensitivity 80–90%, specificity 82–93%). The sensitivity and specificity for influenza or respiratory syncytial virus varied considerably across the different types of tests. Tests involving nucleic acid amplification techniques (either single pathogen or multiplex tests) had the highest diagnostic accuracy for influenza (sensitivity 91–99.8%, specificity 96.8–99.4%). Limitations: Most of the evidence was considered low or very low certainty when assessed with GRADE, due to imprecision in effect estimates, the potential for bias and the inclusion of participants outside the scope of this review (children, or people in hospital). Future work: Currently evidence is insufficient to support routine use of point-of-care tests in primary and emergency care. Further work must establish whether the introduction of point-of-care tests adds value, or simply increases healthcare costs. Funding: This article presents independent research funded by the National Institute for Health and Care Research (NIHR) Health Technology Assessment programme as award number NIHR159948.
- 1 October 2024
- Published by National Institute for Health and Care Research in Health Technology Assessment
- p. 1-75
Open AccessDiagnostic accuracy of point-of-care tests for acute respiratory infection: a systematic review of reviews
Background: Acute respiratory infections are a common reason for consultation with primary and emergency healthcare services. Identifying individuals with a bacterial infection is crucial to ensure appropriate treatment. However, it is also important to avoid overprescription of antibiotics, to prevent unnecessary side effects and antimicrobial resistance. We conducted a systematic review to summarise evidence on the diagnostic accuracy of symptoms, signs and point-of-care tests to diagnose bacterial respiratory tract infection in adults, and to diagnose two common respiratory viruses, influenza and respiratory syncytial virus. Methods: The primary approach was an overview of existing systematic reviews. We conducted literature searches (22 May 2023) to identify systematic reviews of the diagnostic accuracy of point-of-care tests. Where multiple reviews were identified, we selected the most recent and comprehensive review, with the greatest overlap in scope with our review question. Methodological quality was assessed using the Risk of Bias in Systematic Reviews tool. Summary estimates of diagnostic accuracy (sensitivity, specificity or area under the curve) were extracted. Where no systematic review was identified, we searched for primary studies. We extracted sufficient data to construct a 2 × 2 table of diagnostic accuracy, to calculate sensitivity and specificity. Methodological quality was assessed using the Quality Assessment of Diagnostic Accuracy Studies version 2 tool. Where possible, meta-analyses were conducted. We used GRADE to assess the certainty of the evidence from existing reviews and new analyses. Results: We identified 23 reviews which addressed our review question; 6 were selected as the most comprehensive and similar in scope to our review protocol. These systematic reviews considered the following tests for bacterial respiratory infection: individual symptoms and signs; combinations of symptoms and signs (in clinical prediction models); clinical prediction models incorporating C-reactive protein; and biological markers related to infection (including C-reactive protein, procalcitonin and others). We also identified systematic reviews that reported the accuracy of specific tests for influenza and respiratory syncytial virus. No reviews were found that assessed the diagnostic accuracy of white cell count for bacterial respiratory infection, or multiplex tests for influenza and respiratory syncytial virus. We therefore conducted searches for primary studies, and carried out meta-analyses for these index tests. Overall, we found that symptoms and signs have poor diagnostic accuracy for bacterial respiratory infection (sensitivity ranging from 9.6% to 89.1%; specificity ranging from 13.4% to 95%). Accuracy of biomarkers was slightly better, particularly when combinations of biomarkers were used (sensitivity 80–90%, specificity 82–93%). The sensitivity and specificity for influenza or respiratory syncytial virus varied considerably across the different types of tests. Tests involving nucleic acid amplification techniques (either single pathogen or multiplex tests) had the highest diagnostic accuracy for influenza (sensitivity 91–99.8%, specificity 96.8–99.4%). Limitations: Most of the evidence was considered low or very low certainty when assessed with GRADE, due to imprecision in effect estimates, the potential for bias and the inclusion of participants outside the scope of this review (children, or people in hospital). Future work: Currently evidence is insufficient to support routine use of point-of-care tests in primary and emergency care. Further work must establish whether the introduction of point-of-care tests adds value, or simply increases healthcare costs. Funding: This article presents independent research funded by the National Institute for Health and Care Research (NIHR) Health Technology Assessment programme as award number NIHR159948.
- Open Access
- 25 January 2024
- Published by MDPI AG in Healthcare
- Vol. 12 (3) , 316
Adolescent Young Carers Who Provide Care to Siblings
A child’s disability, long-term illness, or mental ill-health is known to affect siblings’ health, social life, school engagement, and quality of life. This article addresses a research gap by its focus on young sibling carers and the impact of providing care to a sibling. A cross-national survey study was conducted in 2018–2019 (Italy, the Netherlands, Slovenia, Sweden, Switzerland, the UK) to examine the incidence of adolescent sibling carers, the extent of care they provide, and their self-reported health, well-being, and school situation. The survey was completed by 7146 adolescents, aged 15–17, and 1444 of them provided care to family members with health-related conditions. Out of these, 286 were identified as Sibling Carers and 668 as Parent Carers, while 181 had both sibling(s) and parent(s) with health-related conditions, and thus were identified as Sibling–Parent Carers. Sibling Carers and Sibling–Parent Carers carried out higher levels of caring activities compared to Parent Carers. They reported both positive aspects of caring, such as increased maturity, and negative aspects, such as mental ill-health, impact on schooling and a lack of support. To reduce the negative aspects of a sibling carer role, it is important to recognise them and to implement early preventive measures and formal support.
- 25 January 2024
- Published by MDPI AG in Healthcare
- Vol. 12 (3) , 316
Open AccessAdolescent Young Carers Who Provide Care to Siblings
A child’s disability, long-term illness, or mental ill-health is known to affect siblings’ health, social life, school engagement, and quality of life. This article addresses a research gap by its focus on young sibling carers and the impact of providing care to a sibling. A cross-national survey study was conducted in 2018–2019 (Italy, the Netherlands, Slovenia, Sweden, Switzerland, the UK) to examine the incidence of adolescent sibling carers, the extent of care they provide, and their self-reported health, well-being, and school situation. The survey was completed by 7146 adolescents, aged 15–17, and 1444 of them provided care to family members with health-related conditions. Out of these, 286 were identified as Sibling Carers and 668 as Parent Carers, while 181 had both sibling(s) and parent(s) with health-related conditions, and thus were identified as Sibling–Parent Carers. Sibling Carers and Sibling–Parent Carers carried out higher levels of caring activities compared to Parent Carers. They reported both positive aspects of caring, such as increased maturity, and negative aspects, such as mental ill-health, impact on schooling and a lack of support. To reduce the negative aspects of a sibling carer role, it is important to recognise them and to implement early preventive measures and formal support.
- Open Access
- 1 November 2023
- Published by MDPI AG in Healthcare
- Vol. 11 (21) , 2876
Adolescent Young Carers Who Provide Help and Support to Friends
Prior studies emphasize the value of friends’ support for children/adolescents who have a disability or suffer from mental ill-health or a long-term illness. However, few studies have explored how a caring role affects those young friend carers themselves. This paper addresses a gap in the research by focusing on this hitherto neglected group of young carers to explore the impact of providing care to friends. An online survey was employed for a cross-national study conducted in 2018–2019 in Sweden, Italy, Slovenia, the Netherlands, Switzerland, and the United Kingdom to examine the incidence of adolescent young friend carers, the extent of care they provide, and their self-reported health, well-being, and school situation. The survey was completed by 7146 adolescents, aged 15–17, and 1121 of them provided care to a friend with a health-related condition, most frequently mental ill-health. They carried out high levels of caring activities, and a quarter of them also provided care to a family member. They experienced both positive and negative aspects of caring. Nevertheless, in comparison with adolescents who provided care to family members, they reported more health problems, with a dominance of mental ill-health, and they received lower levels of support. Since adolescent friends play a valuable role for young people with health-related conditions, especially mental ill-health, it is important to find ways of optimizing their caring experiences in order that those adolescents who choose to care for a friend can do so without it having a negative impact on their own mental health, well-being, and life situation.
- 1 November 2023
- Published by MDPI AG in Healthcare
- Vol. 11 (21) , 2876
Open AccessAdolescent Young Carers Who Provide Help and Support to Friends
Prior studies emphasize the value of friends’ support for children/adolescents who have a disability or suffer from mental ill-health or a long-term illness. However, few studies have explored how a caring role affects those young friend carers themselves. This paper addresses a gap in the research by focusing on this hitherto neglected group of young carers to explore the impact of providing care to friends. An online survey was employed for a cross-national study conducted in 2018–2019 in Sweden, Italy, Slovenia, the Netherlands, Switzerland, and the United Kingdom to examine the incidence of adolescent young friend carers, the extent of care they provide, and their self-reported health, well-being, and school situation. The survey was completed by 7146 adolescents, aged 15–17, and 1121 of them provided care to a friend with a health-related condition, most frequently mental ill-health. They carried out high levels of caring activities, and a quarter of them also provided care to a family member. They experienced both positive and negative aspects of caring. Nevertheless, in comparison with adolescents who provided care to family members, they reported more health problems, with a dominance of mental ill-health, and they received lower levels of support. Since adolescent friends play a valuable role for young people with health-related conditions, especially mental ill-health, it is important to find ways of optimizing their caring experiences in order that those adolescents who choose to care for a friend can do so without it having a negative impact on their own mental health, well-being, and life situation.
- Open Access
- 1 February 2023
- Published by Bristol University Press in International Journal of Care and Caring
- Vol. 7 (1) , 6-32
The first cross-national study of adolescent young carers aged 15–17 in six European countries
For the first time, this article will provide a cross-national profile of adolescents who provide unpaid care to their ill or disabled family members in six European countries with varied levels of awareness, policy and service provision regarding adolescent young carers. Utilising an online survey, 2,099 adolescent young carers were identified in Italy, the Netherlands, Slovenia, Sweden, Switzerland and the UK. This article focuses on the impact of unpaid care on their mental health, well-being, physical health and education. Their preferences for informal and formal support were also examined. These groundbreaking findings help promote a ‘rights’ approach to adolescent young carers, which can serve as a critical driver for supportive policy creation on both a country-specific and pan-European level.
- 1 February 2023
- Published by Bristol University Press in International Journal of Care and Caring
- Vol. 7 (1) , 6-32
Open AccessThe first cross-national study of adolescent young carers aged 15–17 in six European countries
For the first time, this article will provide a cross-national profile of adolescents who provide unpaid care to their ill or disabled family members in six European countries with varied levels of awareness, policy and service provision regarding adolescent young carers. Utilising an online survey, 2,099 adolescent young carers were identified in Italy, the Netherlands, Slovenia, Sweden, Switzerland and the UK. This article focuses on the impact of unpaid care on their mental health, well-being, physical health and education. Their preferences for informal and formal support were also examined. These groundbreaking findings help promote a ‘rights’ approach to adolescent young carers, which can serve as a critical driver for supportive policy creation on both a country-specific and pan-European level.